Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae
Authors
Keywords
-
Journal
EYE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-28
DOI
10.1038/s41433-020-01379-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
- (2020) Paulina Liberman et al. CORNEA
- Conjunctivitis in dupilumab clinical trials
- (2019) B. Akinlade et al. BRITISH JOURNAL OF DERMATOLOGY
- Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
- (2019) J.P. Thyssen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study
- (2019) Mette Deleuran et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Keeping an eye on the ocular problems in dupilumab clinical trials
- (2019) Chia‐Yu Chu BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment
- (2019) Yoav Nahum et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Treatment of refractory conjunctivitis associated to dupilumab with topical pimecrolimus applied to the eyelid skin
- (2019) Alvise Sernicola et al. Dermatologic Therapy
- Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?
- (2018) J.P. Thyssen BRITISH JOURNAL OF DERMATOLOGY
- Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
- (2018) Andreas Wollenberg et al. Journal of Allergy and Clinical Immunology-In Practice
- Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
- (2018) Alison D. Treister et al. JAMA Dermatology
- Dupilumab-Induced Follicular Conjunctivitis
- (2018) Elizabeth Shen et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management
- (2018) Russell M. Levine et al. JAMA Dermatology
- Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
- (2017) Jacob P. Thyssen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Atopic keratoconjunctivitis and atopic dermatitis
- (2010) Stefano Guglielmetti et al. Current Opinion in Allergy and Clinical Immunology
- Clinical Review: Topical Ophthalmic Use of Cyclosporin A
- (2010) Canan Asli Utine et al. OCULAR IMMUNOLOGY AND INFLAMMATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search